Home
About
Overview
Sharing Data
ORCID
Help
History (38)
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
An evaluation of the analgesic efficacy of intravenous regional anesthesia with lidocaine and ketorolac using a forearm versus upper arm tourniquet.
Interactions of antibodies and complement on bacterial surfaces: lessons learned from the gonococcus. In Vaccines: New Concepts and Developments. Proceedings of the 10th International Convocation of Immunology. H. Kohler, and P.T. LoVerde (eds). Longman Scientific & Technical, Essex, England, p. 177
Immune effector mechanisms in malaria: An update focusing on human immunity.
See All 38 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immune effector mechanisms in malaria: An update focusing on human immunity.
Moormann AM, Nixon CE, Forconi CS. Immune effector mechanisms in malaria: An update focusing on human immunity. Parasite Immunol. 2019 08; 41(8):e12628.
View in:
PubMed
subject areas
Animals
Antimalarials
Humans
Immune System
Malaria Vaccines
Malaria, Falciparum
Plasmodium falciparum
Vaccination
authors with profiles
Ann M Moormann PhD, MPH
Catherine Suzanne Christin Forconi PhD